Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 59

Results For "CENT"

4841 News Found

Free HLA typing for children with thalassaemia launched in India
Healthcare | May 07, 2026

Free HLA typing for children with thalassaemia launched in India

The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia


China poised to launch world’s first CAR-T therapy for gastric cancer
Biopharma | May 07, 2026

China poised to launch world’s first CAR-T therapy for gastric cancer

As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies


Neurobion introduces nerve pain relief cream
Healthcare | May 07, 2026

Neurobion introduces nerve pain relief cream

The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil


GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD
Clinical Trials | May 07, 2026

GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD

This is an exciting and meaningful milestone for GRIN Therapeutics


Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum
News | May 07, 2026

Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum

The standout story remains Wegovy, particularly its new oral formulation


Eli Lilly unveils $4.5 bn Indiana expansion
News | May 07, 2026

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies


DCDC Health Services expands dialysis network across Uttar Pradesh under PPP model
Healthcare | May 06, 2026

DCDC Health Services expands dialysis network across Uttar Pradesh under PPP model

The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions


Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints
Biopharma | May 06, 2026

Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints

The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients


Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal
News | May 06, 2026

Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal

The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty